Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Feb 26, 2020, after the close
10-K filed Feb 27, 2020, 58 days after period end · 0001564590-20-006889
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $98.33M | $59.57M | $43.56M | $11.96M |
| Net Income | -$53.04M | -$65.49M | -$68.87M | -$78.70M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.34 |
| -$0.50 |
| -$0.55 |
| -$0.65 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
